Demand for weight loss medications is skyrocketing, with prescriptions for Wegovy doubling and Zepbound tripling in just a year. However, these drugs come with hefty price tags and often lack insurance coverage. The podcast also delves into Australia’s rising wholesale prices and the ongoing negotiations in the media industry. Meanwhile, it explores the turmoil in France’s economy amid political fragmentation, revealing how inflation impacts daily life in Paris.
The surge in prescriptions for weight loss drugs like Wegovy and Zepbound reflects a rising public interest that manufacturers struggle to meet.
High costs of these medications, combined with limited insurance coverage, create significant financial barriers for individuals seeking weight loss solutions.
Deep dives
Rising Popularity and Cost of Weight Loss Drugs
Prescriptions for weight loss drugs like Wagovi and Zep Bound have surged significantly, indicating a growing public interest in these medications. The rising demand has led to challenges in manufacturing, as companies struggle to keep up with the influx of orders. However, the high cost of these drugs, generally ranging from $1,000 to $1,500 a month, remains a substantial barrier for many patients. Most health insurance plans do not fully cover weight loss medications, forcing individuals to pay steep out-of-pocket expenses, sometimes exceeding $2,500 annually even with insurance.
Insurance Limitations and Public Perception
Insurance coverage for weight loss drugs is limited, with less than 20 percent of large employer-sponsored plans providing coverage, and many plans under the Affordable Care Act offering little to no support. This misconception can lead patients to believe they are adequately insured when, in reality, they may face exorbitant costs. Experts highlight that while many people are seeking these medications, the financial implications can be overwhelming, leading to greater economic strain on individuals. As more media discussions promote these weight loss solutions, the gap between demand and accessibility continues to widen.
1.
The Rising Costs and Demand for Weight Loss Medications
Prescriptions for Wegovy have doubled and prescriptions for Zepbound have tripled in the past year, according to a recent report from GoodRx, a company that searches for deals on medicines. Weight loss drugs are pricey though, and insurance plans often don’t cover them if they’re used for weight loss. We’ll hear about some of the wins for those in the business of losing. Also on this morning’s show: Australia’s news tax and France’s disarrayed economy.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode